Treatment-resistant recurrent membranoproliferative glomerulonephritis in renal allograft responding to rituximab: Case report

Transplantation Proceedings

Volumn 47, Issue 3, 2015, Pages 823-826

  Farooqui, M ^a   Alsaad, K ^b   Aloudah, N ^a   Alhamdan, H ^a  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CREATININE; DIURETIC AGENT; GANCICLOVIR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISONE; RITUXIMAB; TACROLIMUS; IMMUNOLOGIC FACTOR;

ADULT; ANASARCA; ANTIBIOTIC THERAPY; ATROPHY; BONE MARROW CULTURE; BONE MARROW EXAMINATION; BRONCHIOLITIS OBLITERANS; CASE REPORT; CONFERENCE PAPER; COUGHING; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DIURETIC THERAPY; DRUG WITHDRAWAL; DYSPNEA; GENERALIZED EDEMA; GLOMERULUS CAPILLARY; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY TRANSPLANTATION; LUNG BIOPSY; LUNG EDEMA; LUNG TUBERCULOSIS; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NEPHROSCLEROSIS; ORGANIZING PNEUMONIA; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; RELAPSE; REMISSION; RENAL REPLACEMENT THERAPY; VIRUS PNEUMONIA; ALLOTRANSPLANTATION; BLOOD; DRUG PULSE THERAPY; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; KIDNEY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PATHOPHYSIOLOGY; TREATMENT FAILURE;

COMBINED MODALITY THERAPY; CREATININE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNOLOGIC FACTORS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PLASMAPHERESIS; PROTEINURIA; PULSE THERAPY, DRUG; RECURRENCE; RITUXIMAB; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE;

EID: 84928341367     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2015.02.003     Document Type: Conference Paper

References (29)

1. T. Alatif, O. Maoujoud, and I. Montasser Glomerular disease in military hospital of Morocco: review of single center renal biopsy database on adults Indian J Nephrol 22 2012 257 263
2. M. Rabbani, G. Memon, and B. Ahmad Percutaneous renal biopsy results: a retrospective analysis of 511 consecutive cases Saudi J Kidney Dis Transpl 23 2012 614 618
3. Y. Wu, Z. Wang, and H. Xu Frequency of primary glomerular disease in northeastern China Braz J Med Biol Res 44 2011 810 813
4. U. Das, K. Dakshinamurthy, and A. Prayaga Pattern of biopsy proven renal disease in a single center of South India: 19 years experience Indian J Nephrol 21 2011 250 257
5. C. Ponticelli, and R. Glassock Post transplant recurrence of primary glomerulonephritis Clin J Am Soc Nephrol 5 2010 2363 2372
6. E.C. Lorenz, S. Sethi, N. Leung, A. Dispenzieri, F. Feryenza, and F.G. Cosio Recurrent membranoproliferative glomerulonephritis after kidney transplantation Kidney Int 77 2010 721 728
7. W. Salwa-Zurawska, E. Bortkiewicz, A. Woźniak, G. Dworacki, and J. Maciejewski Morphological and clinical aspects of membrano-proliferative glomerulonephritis in children Pol J Pathol 47 1996 215 224
8. M.B. Abdurrahman, A.T. Elidrissy, F.H. Shipkey, S. al Rasheed, and M. al Mugeiren Clinicopathological features of childhood nephrotic syndrome in Saudi Arabia Ann Trop Paediatr 10 1990 125 132
9. J.S. Cameron, D.R. Turner, and J. Heaton Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis Am J Med 74 1983 175 192
10. B.E. Vikse, L. Bostad, K. Aasarød, D.E. Lysebo, and B.M. Iversen Prognostic factors in mesangioproliferative glomerulonephritis Nephrol Dial Transplant 17 2002 1603 1613
11. G. Moroni, C. Casati, and S. Quaglini Membranoproliferative glomerulonephritis type I in renal transplantation patients: a single-center study of a cohort of 68 renal transplants followed up for 11 years Transplantation 91 2011 1233 1239
12. M.B. Andresdottir, K.J. Assmann, A.J. Hoitsma, R.A. Koene, and J.F. Wetzels Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: analysis of the incidence, risk factors, and impact on graft survival Transplantation 63 1997 1628 1633
13. M.C. Braun, D.M. Stablein, L.A. Hamiwka, L. Bell, S.M. Bartosh, and C.F. Strife Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: the North American Pediatric Renal Transplant Cooperative Study experience J Am Soc Nephrol 16 2005 2225 2233
14. S. Hariharan, M.B. Adams, and D.C. Brennan Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR) Transplantation 68 1999 635 641
15. A. Damodar, R. Mustafa, and J. Bhatnagar Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritis Clin Transplant 25 2011 375 379
16. A.L. Sellier-Leclerc, V. Baudouin, and T. Kwon Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood - follow-up after CD19 recovery Nephrol Dial Transplant 27 2012 1083 1089
17. S. Emre, A. Sirin, H. Alpay, F. Tanman, V. Uysal, and A. Nayir Pulse methylprednisolone therapy in children with membranoproliferative glomerulonephritis Acta Paediatr Jpn 37 1995 626 629
18. J.M. Bergstein, and S.P. Andreoli Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy Pediatr Nephrol 9 1995 268 271
19. I. Zäuner, J. Böhler, N. Braun, C. Grupp, P. Heering, and P. Schollmeyer Collaborative Glomerulonephritis Therapy Study Group (CGTS). Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial Nephrol Dial Transplant 9 1994 619 622 Erratum: Nephrol Dial Transplant 1994;9:1526
20. O. Harmankaya, T. Baştürk, Y. Oztürk, N. Karabiber, and A. Obek Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I Int Urol Nephrol 33 2001 583 587
21. D.C. Cattran, C.J. Cardella, and J.M. Roscoe Results of a controlled drug trial in membranoproliferative glomerulonephritis Kidney Int 27 1985 436 441
22. H. Töz, E. Ok, A. Unsal, G. Aşçi, G. Başdemir, and A. Başçi Effectiveness of pulse cyclophosphamide plus oral steroid therapy in idiopathic membranoproliferative glomerulonephritis Nephrol Dial Transplant 12 1997 1081 1082
23. M. Yuan, J. Zou, X. Zhang, H. Liu, J. Teng, and Y. Zhong Combination therapy with mycophenolate mofetil and prednisone in steroid-resistant idiopathic membranoproliferative glomerulonephritis Clin Nephrol 73 2010 354 359
24. S. De, D. Al-Nabhani, P. Thorner, D. Cattran, T.D. Piscione, and C. Licht Remission of resistant MPGN type I with mycophenolate mofetil and steroids Pediatr Nephrol 24 2009 597 600
25. W.Y. Kong, R. Swaminathan, and A. Irish Our experience with rituximab therapy for adult-onset primary glomerulonephritis and review of literature Int Urol Nephrol 45 2013 795 802
26. J.J. Dillon, M. Hladunewich, W.E. Haley, H.N. Reich, D.C. Cattran, and F.C. Fervenza Rituximab therapy for type I membranoproliferative glomerulonephritis Clin Nephrol 77 2012 290 295
27. A.V. Hadjinicolaou, M.K. Nisar, S. Bhagat, H. Parfrey, E.R. Chilvers, and A.J. Ostör Noninfectious pulmonary complications of newer biological agents for rheumatic diseases - a systematic literature review Rheumatology (Oxford) 50 2011 2297 2305
28. J.E. Gottenberg, P. Ravaud, and T. Bardin Autoimmunity and Rituximab Registry, French Society of Rheumatology. Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the Autoimmunity and Rituximab Registry Arthritis Rheum 62 2010 2625 2632
29. X. Liu, X.N. Hong, Y.J. Gu, B.Y. Wang, Z.G. Luo, and J. Cao Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma Leuk Lymphoma 49 2008 1778 1783